Cancer Health Treatment Update Exercise Can Lower Cancer Risk and Improve Survival Just a few minutes a day of vigorous physical activity was linked to reduced cancer risk. Adding Immunotherapy to Local Treatment Delays Liver Cancer Progression Combining Imfinzi and Avastin with TACE led to better treatment outcomes. Menin Inhibitor Shows Promise for Acute Leukemia About 1 in 4 adults and children treated with revumenib achieved complete remission. World Cancer Day: UICC Offers Actionable Recommendations to Close the Care Gap Global call to action and release of the World Cancer Day 2024 Equity Report. Cancer Health Winter 2024 Check out our new print edition! Advertisement Senate Hearing Highlights Long COVID Crisis Hearing focuses on long COVID—but not COVID-19 prevention—as advocacy groups bring their demands to DC. More News About COVID-19 See our coverage of COVID-19, including how it affects people living with cancer. For more news about the SARS-CoV-2 coronavirus, visit our sister site, COVID Health.com. Newsfeed World Cancer Day: UICC Offers Actionable Recommendations to Close the Care Gap World Cancer Day 2024 Challenges Those in Power [VIDEO] Leading Oncology Organization Issues Call-to-Action to Expand Access to Clinical Trials Blood Test Distinguishes Neuroendocrine Subtype of Advanced Prostate Cancer Blog: National Cancer Institute Can Some People with Breast Cancer Safely Skip Lymph Node Radiation? Removing Stomach to Prevent Cancer Has Lasting Consequences Xtandi Gets Added Approval for High-Risk Prostate Cancer FDA Approves Loqtorzi for Advanced Nasopharyngeal Cancer Newsfeed World Cancer Day: UICC Offers Actionable Recommendations to Close the Care Gap World Cancer Day 2024 Challenges Those in Power [VIDEO] Leading Oncology Organization Issues Call-to-Action to Expand Access to Clinical Trials Blood Test Distinguishes Neuroendocrine Subtype of Advanced Prostate Cancer Blog: National Cancer Institute Can Some People with Breast Cancer Safely Skip Lymph Node Radiation? Removing Stomach to Prevent Cancer Has Lasting Consequences Xtandi Gets Added Approval for High-Risk Prostate Cancer FDA Approves Loqtorzi for Advanced Nasopharyngeal Cancer

You are receiving this email because you opted in at one of our websites. At your request, this message was sent to newsletter@newslettercollector.com by update@cancerhealth.com. Please remember to add update@cancerhealth.com to your email address book, so that these updates aren't blocked as spam.

To change your subscription information and preferences, please visit your personal preferences page. Or you can unsubscribe completely from this list.

To forward this message, please do not use the forward button of your email application, because this message was made specifically for you only. Instead use the forward page in our newsletter system.

Did you receive this email from a friend? You can subscribe and you will receive our next newsletter directly to your inbox.

Our mailing address is: